Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chalid Assaf

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 6, 2013
Brief S2k guidelines--Merkel cell carcinomaJürgen C Becker, Chalid Assaf, Dirk Vordermark, et al.
The Lancet. Oncology|March 2, 2005
Relapse of primary extranodal marginal-zone B-cell lymphoma of the dura materChalid Assaf, Sarah E Coupland, Michael Hummel, et al.
Experimental Dermatology|May 28, 2014
T-cell receptor gene rearrangement analysis of sequential biopsies in cutaneous T-cell lymphomas with the Biomed-2 PCR reveals transient T-cell clones in addition to the tumor cloneDaniel Humme, Ansgar Lukowsky, Maria Gierisch, et al.
Journal of Cutaneous Pathology|December 24, 2003
Verrucous carcinoma of the axilla: case report and reviewChalid Assaf, Matthias Steinhoff, Ivailo Petrov, et al.
The Journal of Investigative Dermatology|November 6, 2009
Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIPFrank K Braun, Burkhard Hirsch, Nadya Al-Yacoub, et al.
Leukemia & Lymphoma|July 29, 2008
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in primary cutaneous B-cell lymphomas: first results of a prospective, monocentre studySofiane Maza, Sylke Gellrich, Chalid Assaf, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 9, 2019
Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndromeKhaled Elsayad, Kai Kroeger, Burkhard Greve, et al.
The Journal of Investigative Dermatology|November 3, 2025
Corrigendum to 'Resistance of Cutaneous Anaplastic Large-Cell Lymphoma Cells to Apoptosis by Death Ligands Is Enhanced by CD30-Mediated Overexpression of c-FLIP': Journal of Investigative Dermatology, Volume 130, Issue 3, March 2010, Pages 826-840Frank K Braun, Burkhard Hirsch, Nadya Al-Yacoub, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphomaH Miles Prince, Madeleine Duvic, Ann Martin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2013
Treatment of advanced cutaneous T-cell lymphomas with non-pegylated liposomal doxorubicin--consensus of the lymphoma group of the Working Group Dermatologic OncologyChalid Assaf, Jürgen C Becker, Marc Beyer, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 6, 2013
Brief S2k guidelines--Merkel cell carcinomaJürgen C Becker, Chalid Assaf, Dirk Vordermark, et al.
The Lancet. Oncology|March 2, 2005
Relapse of primary extranodal marginal-zone B-cell lymphoma of the dura materChalid Assaf, Sarah E Coupland, Michael Hummel, et al.
Experimental Dermatology|May 28, 2014
T-cell receptor gene rearrangement analysis of sequential biopsies in cutaneous T-cell lymphomas with the Biomed-2 PCR reveals transient T-cell clones in addition to the tumor cloneDaniel Humme, Ansgar Lukowsky, Maria Gierisch, et al.
Journal of Cutaneous Pathology|December 24, 2003
Verrucous carcinoma of the axilla: case report and reviewChalid Assaf, Matthias Steinhoff, Ivailo Petrov, et al.
The Journal of Investigative Dermatology|November 6, 2009
Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIPFrank K Braun, Burkhard Hirsch, Nadya Al-Yacoub, et al.
Leukemia & Lymphoma|July 29, 2008
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in primary cutaneous B-cell lymphomas: first results of a prospective, monocentre studySofiane Maza, Sylke Gellrich, Chalid Assaf, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 9, 2019
Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndromeKhaled Elsayad, Kai Kroeger, Burkhard Greve, et al.
The Journal of Investigative Dermatology|November 3, 2025
Corrigendum to 'Resistance of Cutaneous Anaplastic Large-Cell Lymphoma Cells to Apoptosis by Death Ligands Is Enhanced by CD30-Mediated Overexpression of c-FLIP': Journal of Investigative Dermatology, Volume 130, Issue 3, March 2010, Pages 826-840Frank K Braun, Burkhard Hirsch, Nadya Al-Yacoub, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphomaH Miles Prince, Madeleine Duvic, Ann Martin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2013
Treatment of advanced cutaneous T-cell lymphomas with non-pegylated liposomal doxorubicin--consensus of the lymphoma group of the Working Group Dermatologic OncologyChalid Assaf, Jürgen C Becker, Marc Beyer, et al.
Pageof 13